Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2974-2020Class II

Accelerator a3600 system with Sysmex XN-9000/XN-9100 Interface Module (dual robot) FLX-290-10; FLX-290-20 and...

Inpeco S.p.A. / initiated 2020-08-07 / Terminated / root cause: software

Inpeco S.A. began a recall of Accelerator a3600 system with Sysmex XN-9000/XN-9100 Interface Module (dual robot) FLX-290-10; FLX-290-20 and Track to Rack Module FLX-295-10- Intended... on . FDA classified it as Class II and gives the reason as "Firmware of the Sysmex XN-9000/XN-9100 Interface Module (IM) and of the Track to Rack Module has the potential to mis-associate sample IDs leading to incorrect results or delayed results". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-2974-2020
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Inpeco S.p.A.
Product
Accelerator a3600 system with Sysmex XN-9000/XN-9100 Interface Module (dual robot) FLX-290-10; FLX-290-20 and Track to Rack Module FLX-295-10- Intended Clinical Chemistry Test Systems - Product Usage: The FlexLab 3.6 Automation is a modular system designed to automate Pre-Analytical and Post-Analytical processing, sample handling in order to automate sample processing in the Laboratory. The system consolidates analytical instruments, such as the ARCHITECT c8000 System into a unified workstation that perform a variety of instrument specific assays such as Sodium, Potassium and Chloride. Sodium, Potassium and Chloride measurements are used in the diagnosis and treatment of diseases involving electrolyte imbalance.
Product code
CEM Electrode, Ion Specific, Potassium
Reason for recall
Firmware of the Sysmex XN-9000/XN-9100 Interface Module (IM) and of the Track to Rack Module has the potential to mis-associate sample IDs leading to incorrect results or delayed results
Root cause tag
software
FDA root cause
Software design
Action
Inpeco issued Customer Letter dated August 7, 2020 forwarded to the customers either by Inpeco (for the laboratories where Inpeco is directly the distributor) or by the Inpeco distributors. Letter states reason for recall, health risk and action to take: customers impacted by the Field Action have to complete and return the Recall Letter Receipt Confirmation and Implementation Check form attached to the Customer letter within 15 days to Inpeco or the distributor. The customers impacted by the issue will be contacted by Inpeco or the distributors to arrange a visit to upgrade the impacted modules firmware. Contact reference person: Eva Balzarotti - Regulatory Affairs Manager. E-mail: [email protected] Phone: (+41) 919118 224
Quantity in commerce
2 US and 6 OUS
Distribution
Worldwide distribution - US Nationwide distribution including in the states of AK, FL, IA, LA, MA, MS, MT, NC, OH, TX, VA and the countries of AUSTRALIA, AUSTRIA, BELGIUM, DENMARK, FRANCE, GERMANY, ITALY, JAPAN, NETHERLANDS. NORWAY SAUDI ARABIA SOUTH KOREA SWEDEN UNITED ARAB EMIRATES
Product codes and lots
Serial Numbers: US: ACP.413 ACP.424  OUS: ACP.349 ACP.399 ACP.400 ACP.410 ACP.252 ACP.290

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2974-2020
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2973-2020Class IITerminatedVoluntary: Firm initiated
Z-2974-2020Class IITerminatedVoluntary: Firm initiated
Z-2975-2020Class IITerminatedVoluntary: Firm initiated